These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11999320)

  • 1. The role of 5alpha-reduction in steroid hormone physiology.
    Wilson JD
    Reprod Fertil Dev; 2001; 13(7-8):673-8. PubMed ID: 11999320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen physiology: unsolved problems at the millennium.
    Wilson JD; Leihy MW; Shaw G; Renfree MB
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):1-5. PubMed ID: 12573808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the alternate pathway of dihydrotestosterone formation in virilization of the Wolffian ducts of the tammar wallaby, Macropus eugenii.
    Shaw G; Fenelon J; Sichlau M; Auchus RJ; Wilson JD; Renfree MB
    Endocrinology; 2006 May; 147(5):2368-73. PubMed ID: 16469812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation.
    Schiffer L; Arlt W; Storbeck KH
    J Steroid Biochem Mol Biol; 2024 Jul; 241():106516. PubMed ID: 38582131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
    Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
    Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
    Negri-Cesi P; Colciago A; Poletti A; Motta M
    Prostate; 1999 Dec; 41(4):224-32. PubMed ID: 10544295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanisms of androgen resistance in 5 alpha-reductase deficiency: implications for the physiological roles of 5 alpha-reductases.
    Hodgins MB
    J Steroid Biochem; 1983 Jul; 19(1B):555-9. PubMed ID: 6887883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of rat testicular 5alpha-reductase type 1 and 2 isoforms by testosterone and FSH.
    Pratis K; O'Donnell L; Ooi GT; Stanton PG; McLachlan RI; Robertson DM
    J Endocrinol; 2003 Mar; 176(3):393-403. PubMed ID: 12630924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of androgens in 5 alpha-reductase-deficient human genital skin fibroblasts: inhibition by progesterone and its metabolites.
    Hodgins MB
    J Endocrinol; 1982 Sep; 94(3):415-27. PubMed ID: 7119651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions.
    Suzuki T; Darnel AD; Akahira JI; Ariga N; Ogawa S; Kaneko C; Takeyama J; Moriya T; Sasano H
    J Clin Endocrinol Metab; 2001 May; 86(5):2250-7. PubMed ID: 11344235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial expression, purification, and reconstitution of human steroid 5α-reductases in phospholipid liposomes and nanodiscs.
    Im SC; Valentín-Goyco J; Peng HM; Auchus RJ
    Methods Enzymol; 2023; 689():263-276. PubMed ID: 37802573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies.
    Nikolaou N; Hodson L; Tomlinson JW
    J Steroid Biochem Mol Biol; 2021 Mar; 207():105808. PubMed ID: 33418075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of androgen synthesis via 5alpha-reduced precursors.
    Ghayee HK; Auchus RJ
    Endocr Dev; 2008; 13():55-66. PubMed ID: 18493133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen-activating enzymes in the central nervous system.
    Poletti A; Martini L
    J Steroid Biochem Mol Biol; 1999; 69(1-6):117-22. PubMed ID: 10418985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma.
    Tanaka S; Miki Y; Hashimoto C; Takagi K; Doe Z; Li B; Yaegashi N; Suzuki T; Ito K
    Mol Cell Endocrinol; 2015 Feb; 401():56-64. PubMed ID: 25475427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens.
    Schmidt M; Weidler C; Naumann H; Anders S; Schölmerich J; Straub RH
    Arthritis Res Ther; 2005; 7(5):R938-48. PubMed ID: 16207335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of androgen action--a historical perspective.
    Brinkmann AO
    Methods Mol Biol; 2011; 776():3-24. PubMed ID: 21796517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dihydrotestosterone in benign prostatic hyperplasia.
    Carson C; Rittmaster R
    Urology; 2003 Apr; 61(4 Suppl 1):2-7. PubMed ID: 12657354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dihydrotestosterone in androgen action.
    Wilson JD
    Prostate Suppl; 1996; 6():88-92. PubMed ID: 8630237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone.
    Grino PB; Griffin JE; Wilson JD
    Endocrinology; 1990 Feb; 126(2):1165-72. PubMed ID: 2298157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.